The DNA-test technology company, Athgene was sold to Nordic Laboratories.

Athgene went through an intensive, exploratory process with Gemstone Capital as its exclusive advisor. Several options were investigated and in the end, it was decided to pursue an industrial sale of Athgene.
As a result the company was sold to Nordic Laboratories.

Yusufa Sey, the found and CEO of Athgene commented: “It was great to work with Gemstone Capital. Quickly, they got their heads and arms around the situation, including the challenges and opportunities at hand. We considered an IPO and were introduced to specialists and investors. In parallel, we worked intensively on our strategic options with Gemstone as a strong source of inspiration and competence. I enjoyed the process and would recommend Gemstone to anyone in need of more than just the transaction”.